This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Seeks Patients.
—The National Eye Institute, Bethesda, Md, is sponsoring a multicenter study of retinopathy of prematurity that began in January 1986. The study will both evaluate cryotherapy as an interdictory treatment and clarify the natural history of the disease.There are 23 participating centers, including more than 70 hospitals. Premature infants who weigh less than 1251 g at birth and meet medical criteria are eligible. Those with retinopathy of prematurity at stage 3+ and no detached retina can be referred to the study for possible cryotherapy of one eye (if they meet the entry criteria).The following centers can be contacted: Birmingham, Ala, Frederick Elsas, MD; Sacramento, Calif, Alan Roth, MD; Miami, John T. Flynn, MD; Chicago, Marilyn Miller, MD; Indianapolis, Forrest Ellis, MD; Louisville, Charles Barr, MD; New Orleans, Robert Gordon, MD; Baltimore, Serge de Bustros, MD; Detroit, Michael Trese,
News and Comment. Arch Ophthalmol. 1986;104(10):1442. doi:10.1001/archopht.1986.01050220036011